The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistanceHatim Sati, Elena Carrara, Alessia Savoldi et al.|The Lancet Infectious Diseases|2025Cited by 526
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globallyTiziana Masini, Dennis Falzon, Kerri Viney et al.|European Respiratory Journal|2022Cited by 11